VIR Combination
NDC 43742-2357, Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I, Herpes Simplex II Nosode, Human Herpesvirus 6A, Influenzinum, liquid, from Deseret Biologicals, Inc..
- Product NDC
- 43742-2357
- Status
- Listed
- Labeler
- Deseret Biologicals, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43742-2357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN12 [hp_C]/mL
- HUMAN HERPESVIRUS 518 [hp_X]/mL
- HERRING SPERM DNA12 [hp_X]/mL
- HUMAN HERPESVIRUS 416 [hp_C]/mL
- HEPATITIS B VIRUS33 [hp_X]/mL
- HUMAN HERPESVIRUS 115 [hp_X]/mL
- HUMAN HERPESVIRUS 215 [hp_X]/mL
- HUMAN HERPESVIRUS 615 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE12 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE12 [hp_C]/mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Live Human Adenovirus Type 4 Vaccine [EPC]; Vaccines, Adenovirus [Chemical/Ingredient]; Vaccines, Live, Unattenuated [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43742-2357-1 | 43742235701 | 30 mL in 1 BOTTLE, DROPPER (43742-2357-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43742-2357 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43742-2357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43742-2357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.